Prime Medicine, Inc. (PRME)

Prime Medicine Stock Forecast

Stock Price Forecast

According to 4 professional analysts, the 12-month price target for Prime Medicine stock ranges from a low of $4.25 to a high of $18. The average analyst price target of $9.31 forecasts a 148.93% increase in the stock price over the next year.

Price Target: $9.31 (+148.93%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$4.25	$9.31	$9.00	$18
Change	+13.64%	+148.93%	+140.64%	+381.28%

Analyst Ratings

The average analyst rating for Prime Medicine stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	2	2	2	2	2	2
Buy	1	1	1	1	1	1
Hold	3	3	3	3	3	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	6	6	6	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Samantha Semenkow Citigroup	Citigroup	Hold Maintains $5 → $4.25	Hold	Maintains	$5 → $4.25	+13.64%	Nov 11, 2025
Geulah Livshits Chardan Capital	Chardan Capital	Strong Buy Maintains $10 → $9	Strong Buy	Maintains	$10 → $9	+140.64%	Nov 10, 2025
Samantha Semenkow Citigroup	Citigroup	Hold Maintains $1.5 → $4	Hold	Maintains	$1.5 → $4	+6.95%	Aug 12, 2025
Geulah Livshits Chardan Capital	Chardan Capital	Strong Buy Maintains $12 → $10	Strong Buy	Maintains	$12 → $10	+167.38%	Aug 8, 2025
Samantha Semenkow Citigroup	Citigroup	Strong Buy → Hold Downgrades $10 → $1.5	Strong Buy → Hold	Downgrades	$10 → $1.5	-59.89%	May 27, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

8.34M

Increased by 179.58%

from 2.98M

Revenue Next Year

3.00M

Decreased by -64.06%

from 8.34M

EPS This Year

-1.22

from -1.65

EPS Next Year

-0.94

from -1.22

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	5.21M	-	-	-	2.98M	8.34M	3.00M
Revenue Growth	-	-	-	-	-	179.58%	-64.06%
EPS	-1.91	-14.19	-4.19	-2.18	-1.65	-1.22	-0.94
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	13	12

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	37.9M	10.5M
Avg	8.3M	3.0M
Low	2.5M	n/a

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	1,171.2%	25.9%
Avg	179.6%	-64.1%
Low	-15.6%	-

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	-1.11	-0.59
Avg	-1.22	-0.94
Low	-1.42	-1.48

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.